Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric α-synuclein by Hannestad, Jonas et al.
Single-vesicle imaging reveals lipid-selective and stepwise
membrane disruption by monomeric a-synuclein
Downloaded from: https://research.chalmers.se, 2021-08-31 11:02 UTC
Citation for the original published paper (version of record):
Hannestad, J., Rocha, S., Agnarsson, B. et al (2020)
Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric
a-synuclein
Proceedings of the National Academy of Sciences of the United States of America, 117(25): 14178-14186
http://dx.doi.org/10.1073/pnas.1914670117
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
Single-vesicle imaging reveals lipid-selective and
stepwise membrane disruption by
monomeric α-synuclein
Jonas K. Hannestada,1, Sandra Rochab,1, Björn Agnarssona, Vladimir P. Zhdanova,c,
Pernilla Wittung-Stafshedeb,2, and Fredrik Hööka,2
aDivision of Nano and Biological Physics, Department of Physics, Chalmers University of Technology, Gothenburg 41296, Sweden; bDivision of Chemical
Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg 41296, Sweden; and cBoreskov Institute of
Catalysis, Russian Academy of Sciences, Novosibirsk 630090, Russia
Edited by William F. DeGrado, University of California, San Francisco, CA, and approved May 7, 2020 (received for review August 22, 2019)
The interaction of the neuronal protein α-synuclein with lipid
membranes appears crucial in the context of Parkinson’s disease,
but the underlying mechanistic details, including the roles of dif-
ferent lipids in pathogenic protein aggregation and membrane
disruption, remain elusive. Here, we used single-vesicle resolution
fluorescence and label-free scattering microscopy to investigate
the interaction kinetics of monomeric α-synuclein with surface-
tethered vesicles composed of different negatively charged lipids.
Supported by a theoretical model to account for structural changes
in scattering properties of surface-tethered lipid vesicles, the data
demonstrate stepwise vesicle disruption and asymmetric mem-
brane deformation upon α-synuclein binding to phosphatidylgly-
cerol vesicles at protein concentrations down to 10 nM (∼100
proteins per vesicle). In contrast, phosphatidylserine vesicles were
only marginally affected. These insights into structural conse-
quences of α-synuclein interaction with lipid vesicles highlight the
contrasting roles of different anionic lipids, which may be of mech-
anistic relevance for both normal protein function (e.g., synaptic
vesicle binding) and dysfunction (e.g., mitochondrial membrane
interaction).
α-synuclein | single-vesicle scattering | lipid vesicle | membrane interaction
Parkinson’s disease (PD) is the second most common neuro-degenerative disorder and the most frequent movement
disorder today for which there is only symptomatic treatment (1,
2). Assembly of α-synuclein protein into oligomers and amyloid
fibrils has been linked to the molecular basis of PD, with
α-synuclein amyloids being the major content of pathological
neuronal inclusions, the Lewy bodies, found in PD patient brain
cells (3–5). Duplications, triplications and point mutations in the
α-synuclein gene are linked to familial PD cases (6). Despite the
key role of α-synuclein in emergence and progression of PD, the
details of its function remain unknown, but it appears related to
synaptic vesicle release and trafficking, regulation of enzymes
and transporters, and control of the neuronal apoptotic response
(7–9). In accord, α-synuclein, comprising 140 amino acid resi-
dues and with a molecular weight of about 14 kDa, is localized at
presynaptic nerve terminals associated with synaptic vesicles
(10–12). The protein has also been shown to associate with mem-
branes of mitochondria and endoplasmic reticulum and occurs
under physiological conditions in both an intrinsically unstructured
form in the cytosol and a helical state on lipid membranes (13, 14).
The intracellular concentration of α-synuclein is likely in the low
nanomolar range, but may vary between brain cell types and be-
tween intracellular regions. Extracellularly, higher (micromolar
range) concentrations of the protein have been estimated, for ex-
ample, in presynaptic terminals (15).
Recent advancements in bioanalytical techniques have brought
the understanding of molecular mechanisms of α-synuclein mem-
brane toxicity forward. Fluorescence resonance energy transfer
combined with total internal fluorescence imaging on planar supported
lipid bilayers (SLBs) revealed the extraction of lipids from the
bilayer during α-synuclein aggregation (16). A similar membrane
damage induced by the protein was observed by the combined
use of atomic force microscopy and dual polarization interfer-
ometry (17) as well as quartz crystal microbalance with dissipa-
tion (QCM-D) monitoring combined with neutron reflectometry
(18). Studies using a combination of low-angle X-ray scattering,
fluorescence correlation spectroscopy, and coarse-grained molecular
dynamics revealed membrane curvature-dependent binding and
remodeling by α-synuclein (19). Confocal microscopy imaging
of giant lipid vesicles with encapsulated truncated α-synuclein
(residues 1 to 100) showed concomitant protein aggregation
and membrane permeabilization (20). Stimulated emission
depletion imaging and cryoelectron microscopy were combined
to demonstrate a possible role of α-synuclein as a molecular
bridge between adjacent membranes (7), and, presumably, the
protein also promotes dilation of exocytotic fusion pores in
adrenal chromaffin cells and neurons (21). These and numer-
ous related studies have revealed that α-synuclein binds to bi-
ological membranes with different affinity depending on their
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lipid composition and physical properties, and has the ability to
sense and change the bilayer curvature (14, 22–24) leading to
drastic membrane deformation (22, 25).
Further, the protein binding affinity, either in a monomeric or
aggregated state, is strongly dependent on the presence of an-
ionic phospholipids (14, 22, 26–28). The interaction of
α-synuclein with membranes is most likely relevant for both
function and cellular toxicity, but, despite fairly clear indications
that toxic species of α-synuclein affect cellular membranes, the
molecular mechanisms underlying the membrane−protein in-
teraction are not well understood. Besides the complex nature of
the related processes, reasons for the lack of understanding in-
clude the fact that most experiments are performed either by
ensemble-averaging methods or at conditions that do not enable
measurements of rapid dynamics. It is, in this context, relevant to
note that recent studies, based on biophysical investigations us-
ing simplified model membrane systems, suggest that membrane
permeabilization observed for amyloid-forming proteins, in-
cluding α-synuclein, shares key features with the significantly
simpler and therefore often more well-understood process as-
sociated with pore-forming antimicrobial peptides (29). Indeed,
the tremendous attention put on antibacterial peptides has offered
a general understanding of the corresponding mechanistic details
of the pore formation at the conceptual level and at the levels of
statistical models and molecular dynamics simulations (30).
Inspired by these insights and fluorescence microscopy studies
indicating that antimicrobial peptide-induced pore formation
can be followed by gradual remodeling of both giant (31–34) and
smaller vesicles (35), we used, in this work, a similar approach,
but instead focused on the interaction of α-synuclein with
surface-tethered ∼100-nm vesicles made of anionic lipids. While
previous single-vesicle studies (focused on antimicrobial pep-
tides) utilized fluorescence imaging alone (35, 36), we here
employed a variant of surface-sensitive light microscopy that is
capable of resolving, in both fluorescence and label-free scattering
mode, individual vesicles with subsecond temporal resolution (37).
This method was previously used to investigate phospholipase-
induced disintegration of tethered vesicles, revealing a kineti-
cally synchronized reduction in fluorescence and scattering in-
tensity upon the structural changes caused by lipid digestion (37).
In contrast, when lipid vesicles collapse into planar SLB patches
on silica, the reduction in scattering intensity was, with this (38)
and related light scattering microscopy methods (39), observed to
be more dramatic than the corresponding changes in fluorescence
intensity, suggesting that scattering microscopy might reveal
structural alterations not easily detected by other means.
Using this combined fluorescence and scattering microscopy
approach, we here investigated how α-synuclein affects the integrity
of DOPS (1,2-dioleoyl-sn-glycero-3-phospho-L-serine) and DOPG
(1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)) vesicles. The
aim was to explore whether protein-induced structural alterations
could be detected and thereby provide molecular mechanistic in-
sights into the kinetics of α-synuclein interaction with different lipid
bilayers and resulting bilayer structural consequences. The micros-
copy analysis was complemented with conventional ensemble-
averaging measurements using multiparametric surface plasmon
resonance (MP-SPR) and QCM-D, which, combined, are particu-
larly well suited for quantitative analysis of interfacial biomolecular
interactions and investigations of structural changes of surface-
bound lipid vesicles (40–42). To aid data analysis, a theoretical
model representing the label-free light-scattering data was de-
veloped to account for the protein-induced stepwise (some-
times multiple steps) deformation uniquely observed for DOPG
vesicles. Our discovery of strikingly different consequences of
α-synuclein interactions with DOPG versus DOPS vesicles may
have biological relevance given the fact that phosphatidylgly-
cerol (PG) plays an important role in mitochondrial membranes
(43, 44) whereas phosphatidylserine (PS) is found in synaptic vesicle
membranes (45).
Results
α-Synuclein Changes the Viscoelastic Properties of Surface-Tethered
Negatively Charged Lipid Vesicles. Before turning to single-vesicle
measurements, MP-SPR and QCM-D were used to inspect time-
resolved changes in mass and structural properties induced by
α-synuclein binding to surface-tethered DOPG and DOPS vesi-
cles. The vesicles were modified with a small fraction (0.25 mol
%) of biotin lipids for using NeutrAvidin as a tethering linker to
a poly(l-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) modi-
fied sensor surface containing 0.25% PLL-g-PEG-biotin. Upon
addition of 200 nM α-synuclein to either DOPG or DOPS ves-
icles, there was a significant decrease in the resonance frequency
shift (Δf) measured by QCM-D, which was accompanied by an
increase in energy dissipation (ΔD) (Fig. 1A). Controls using
either 1,2-dioleoyl-sn-glycero-3-phosphocholine vesicles or bare
PLL-g-PEG-biotin:PLL-g-PEG surface showed no signs of
α-synuclein interaction (SI Appendix, Fig. S1), verifying that the
responses shown in Fig. 1A are specific.
It is, at first sight, tempting to attribute the decrease in Δf
upon α-synuclein injection (t ≈ 20 min) to an increase in coupled
mass caused by protein binding to the vesicles, whereas the ac-
companying increase in ΔD could be associated with alterations
in the structure and viscoelastic properties of the vesicles. Fol-
lowing this line of reasoning, the subsequent increase in Δf (t ≈
27 min for DOPG and t ≈ 32 min for DOPS) could be inter-
preted as desorption of lipid and/or α-synuclein from the sensor
surface. However, from previous studies, it is known that Δf can
also be influenced by structural changes of adsorbed vesicles,
which, in situations where the molecular mass remains essentially
constant, are dominated by variation in the amount of coupled
solvent (40).
To deconvolute changes in the bound molecular mass from
coupled solvent, we used MP-SPR operated at two wavelengths.
Through this technique, the interface region is probed with ev-
anescent fields of two different decay lengths, allowing the film
thickness (or the size of adsorbed particles) to be directly de-
termined from the ratio between the corresponding responses,
R1/R2. This, in turn, makes it possible both to identify structural
changes of adsorbed vesicles and to improve the accuracy of
mass quantifications (42), which were here done (see SI Ap-
pendix, section 3 for details) by taking into account the film
thickness (SI Appendix, Eqs. S1 and S4 and Fig. S2), the differ-
ence in molecular weight between α-synuclein (∼14 kDa) and
lipids (∼0.8 kDa), and the fact that proteins have a slightly higher
refractive index than lipids (34, 46).
Upon addition of 200 nM α-synuclein, there was, for both DOPG
and DOPS, a monotonic increase in the SPR response by around
5% (Fig. 1B; t ≈ 21 min for DOPG and t ≈ 33 min for DOPS),
which corresponds to binding of ∼150 and 300 α-synuclein mole-
cules per vesicle (assuming a nominal vesicle diameter of ∼120 nm)
in the case of DOPG and DOPS, respectively (SI Appendix, section
3). The lower α-synuclein coverage on DOPG vesicles, despite a
similar SPR response to that observed for DOPS vesicles, is
explained by α-synuclein−induced vesicle contraction of the DOPG
vesicles (Fig. 1C). Binding of α-synuclein to both types of vesicles
confirms that the positive changes in Δf are indeed not due to a loss
of bound lipid and/or α-synuclein, but must instead be attributed to
an effect dominated by structural changes influencing the amount of
water coupled to the immobilized vesicles, which are not expected
to yield significant changes in the SPR response when measured at a
single wavelength. It is worth noting, though, that the temporal
evolution of the R1/R2 ratio actually differs for DOPG and DOPS
vesicles upon addition of α-synuclein. For DOPG, the ratio first
decreased and then increased (Fig. 1C, blue curve), which is in-
dicative of an overall decrease in vesicle size (42), whereas, for

































DOPS, there was essentially no change in the response ratio
(Fig. 1C, red curve), indicating that there is no measurable effect
on the film thickness upon α-synuclein binding. This further sup-
ports that the measured QCM-D response is due to a combination
of protein binding and protein-induced structural changes, espe-
cially for DOPG vesicles. In addition, the different features in the
Δf and ΔD responses for DOPS and DOPG were even more
pronounced at increasing vesicle surface coverages (SI Appendix,
Fig. S3), suggesting that α-synuclein interaction leads to structural
changes sufficiently dramatic to cause lateral interactions between
adjacent vesicles.
α-Synuclein Induces Structural Remodeling of Surface-Tethered DOPG
Vesicles. To gain further information on the structural changes
induced upon α-synuclein binding to lipid vesicles, we performed
experiments at the single-vesicle level by using a custom-built
optical waveguide device that allows simultaneous surface-
sensitive microscopy in fluorescence and (label-free) scattering
mode (37). In this way, both the fluorescence and light-scattering
emission of surface-tethered fluorescently labeled (0.25 mol %
Lissamine rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phos-
phoethanolamine, triethylammonium salt [rhodamine DHPE])
DOPG and DOPS vesicles were monitored upon addition of
α-synuclein (200 nM) under similar conditions as described
above. For DOPG, the changes in the fluorescence before and
after addition of α-synuclein were only minor, whereas, in label-
free scattering mode, the intensity for the major fraction of the
vesicles (∼99%) was drastically diminished (Fig. 2 A–C and
Movie S1). Although the onset of changes in scattering followed
an exponential decay behavior with a time constant of ∼5 s when
averaged over many vesicles (Fig. 2C), the actual scattering intensity
drop on the level of individual vesicles was essentially instantaneous
in time (Fig. 2B, blue curves). This stepwise reduction in scattering
intensity cannot be attributed to complete or partial vesicle
detachment, because the corresponding fluorescence intensity
remained and even increased slightly (Fig. 2B, red curves).
Instead, this feature indicates dramatic single-step structural
changes of the individual vesicles, without removal of lipid
material. Notably, this result is opposed to previous observa-
tions with single-vesicle fluorescence microscopy for antimi-
crobial AH peptides (35) and phospholipid vesicle digestion
(37). In strong contrast to the DOPG vesicles, only ∼5% of the
DOPS vesicles showed this type of behavior in the corre-
sponding fluorescence and scattering emissions upon addition
of α-synuclein, with the majority of the vesicles remaining es-
sentially unaffected (Fig. 2 C–E, SI Appendix, Fig. S4, and
Movie S2).
The extent of the reduction in the scattering intensity was
rather different for distinct DOPG vesicles, and, in rare cases,
the intensity even increased (Fig. 2 B, third panel from the Top
and SI Appendix, Fig. S5). A reproducible feature that deserves
further attention is that, upon exposure to α-synuclein, the
scattering emission of DOPG vesicles was frequently (∼60%)
observed to first slightly increase before suddenly decreasing
(Fig. 2 B, Top panel and SI Appendix, Figs. S4 and S5), with the
average relative increase in scattering intensity being 0.25
(±0.18). In stark contrast, a negligible fraction of the DOPS
vesicles showed a similar increase in response upon α-synuclein
interaction, although the variation in the scattering signal be-
tween individual vesicles was, in that case, fairly large (0.062 ±
0.15) (SI Appendix, Fig. S4). In a previous study, we showed that
protein binding to immobilized lipid vesicles leads to an increase
in scattering intensity, ΔIs, which, to a first approximation, scales
as r4(d + Δd)2, where r is the vesicle radius, d  d ≪ r( ) is the
membrane thickness, and Δd is its increment (37). Using this
relation, the analysis of the initial intensity increase upon
α-synuclein addition yields, on average, only minor changes in
the lipid membrane thickness (Δd < 1 nm). Judging from the
scattering profile alone and this rough estimation, it might seem
reasonable to attribute the increase in intensity to an increase in
membrane thickness due to binding of α-synuclein to the DOPG
vesicles. However, since there was almost no observable change
in the scattering intensity upon binding of α-synuclein to the
DOPS vesicles, and, as α-synuclein binds to both DOPG and
DOPS vesicles according to MP-SPR and QCM-D, the increase
in scattering observed for DOPG is more likely associated with
membrane structural changes upon protein interaction. This in-
terpretation is further supported by the fact that this feature was,
for a significant fraction of the vesicles, followed by an abrupt
decrease in scattering signal (Fig. 2B and SI Appendix, Fig. S5).
These data also show that, for DOPG, there was no correlation
in scattering intensity recorded before, t1, and after, t2,
α-synuclein addition (Fig. 2D). Instead, almost all vesicles were
observed to transit to a state where they scattered at a level just
above the background intensity (Fig. 2E and SI Appendix, Fig.
S5), with an average decrease of 90%. For DOPS, however, the
scattering intensity was largely unaffected, with an average in-
tensity decrease of only 8% (Fig. 2E).
In contrast to the results obtained upon addition of 200 nM
α-synuclein, more diverse types of kinetics were observed in ex-
periments with 20 times lower concentration (10 nM) of
α-synuclein added (Fig. 3 and SI Appendix, Figs. S6–S8). Al-
though the kinetic traces were still dominated (∼95%) by a single
step, abrupt decrease in scattering signal occurring ∼20 to 30 s
Fig. 1. QCM-D and SPR measurements of α-synuclein bound to surface-tethered lipid vesicles. (A) Time evolution of Δf and ΔD upon subsequent addition of
lipid vesicles and α-synuclein to a PLL-g-PEG-biotin:PLL-g-PEG and NeutrAvidin-modified sensor surfaces at a PLL-g-PEG-biotin:PLL-g-PEG ratio of 0.25%.
Addition of α-synuclein started after saturated binding of DOPG or DOPS vesicles and rinsing with pure buffer. (B) Dual wavelength SPR sensorgrams of
changes in the resonance angle shift, R, versus time at λ = 670 nm for the same process as in A, for DOPG (blue) and DOPS (red) vesicles. (C) Time evolution of
changes in the R670/R785 ratio of the SPR response for DOPG (blue) and DOPS (red). In B and C, arrows indicate addition of α-synuclein.
























































after α-synuclein injection (Fig. 3 and SI Appendix, Fig. S6), and
gradual and multistep decreases in scattering profiles from in-
dividual vesicles were also observed (top and middle Right in
Fig. 3 and SI Appendix, Fig. S7), and, in very few cases, even a
small increase or no change in scattering signals were detected
(SI Appendix, Fig. S8). SPR could not resolve the small mass
uptake at 10 nM, but the low uptake already at 200 nM (∼150 α-
synuclein per vesicle at saturated binding) suggests that each
stepwise change is induced by significantly less than 150 α-
synuclein per vesicle. In many traces, it is noteworthy that fluc-
tuations in the scattering signal usually decrease or diminish after
the α-synuclein−induced drop. Physically, the fluctuations of the
scattering signal prior to α-synuclein binding are attributed to a
combination of vesicle wobbling in the z direction (which, due to
the evanescent illumination, results in either increase of decrease
of scattering signal) and minor vesicle shape changes. It is clear
from these data that α-synuclein binding also influences the dy-
namic of the vesicle attachment to the surface.
Fluorescence Imaging Indicates Surface Confinement of Lipids after
α-Synuclein−Induced Vesicle Remodeling. While DOPG vesicles
displayed drastic changes in their scattering properties, the cor-
responding changes in fluorescence emission were only modest.
However, as already noted, the fluorescence was not entirely
unaffected (Fig. 2 A and B). Fig. 4A shows an example of the
fluorescence from individual DOPG lipid vesicles prior to (t1 ≅
0 s) and after (t2 ≅ 20 s) α-synuclein addition and binding (see
also Movie S1). There is a clearly discernible difference between
the two micrographs, with the vesicles appearing both larger and
brighter at t2. As noted above, this is better reflected in the
fluorescence intensity profiles of the vesicles, which also show
how the transition between low and high intensity coincides with
the reduction in scattering intensity (Fig. 2B and SI Appendix,
Fig. S5). Thus, the interaction between α-synuclein and DOPG
membranes leads to a change in vesicle properties that decreases
the scattering signal but increases fluorescence of individual
vesicles. Notably, there was no visible increase in fluorescence
from DOPS vesicles upon α-synuclein addition (Movie S2). Data
Fig. 2. Scattering and fluorescence emission from individual DOPG and DOPS vesicles. (A) Scattering and fluorescence images of DOPG vesicles upon (t1) and
∼20 s after (t2) addition of α-synuclein to a final concentration of 200 nM. The red arrow indicates the same vesicle in both scattering and fluorescence
micrographs. (Scale bar: 2 μm.) (B) Representative scattering and fluorescence intensity profiles of individual DOPG vesicles (after subtraction of dark noise).
(C) Temporal evolution of the fraction of DOPG and DOPS vesicles that remains visible in scattering mode upon α-synuclein addition. The presented data are
assembled from >100 vesicles of each type. (D) Scattering intensity for DOPG and DOPS vesicles at t1 and t2. The yellow line indicates no change in intensity
between t1 and t2. (E) Integrated and normalized scattering intensity of individual DOPG and DOPS vesicles just after addition of α-synuclein (t1) and at the
end of the recording (t2, ∼20 s). The scattering background, determined at three separate spots in an area of the chip surface that did not contain any vesicles,
was subtracted from the vesicle scattering profile before summation of the scattering signal associated with individual vesicles, and the area used to estimate
the scattering intensity of the individual vesicles was obtained from the corresponding fluorescence images determined at the appropriate time points (see
Fig. 4 and main text for elaboration on the temporal evolution of the single-vesicle fluorescence spot size).

































for over a hundred DOPG and DOPS vesicles showed a linear
relationship between fluorescence intensity before and after the
transition between the states (Fig. 4B), but with a slope being
larger than unity for DOPG. This difference is summarized in
Fig. 4C, showing that the fluorescence change follows a normal
distribution with a mean of ∼+35% and ∼−5% for DOPG and
DOPS, respectively. While the minor decrease for DOPS is at-
tributed to fluorophore bleaching, the surface-confined evanes-
cent wave illumination of the waveguide-based microscopy used
here relates the fluorescence emission primarily to the distance
between lipids and surface. Hence, the experimentally observed
increase in fluorescence intensity by about 30% for the DOPG
vesicles (Fig. 4C) can be explained by assuming that the lipids
become located closer to the surface after rupture. In fact, the
increase observed for DOPG is in agreement with what is
expected for vesicles with a nominal diameter of ∼120 nm
collapsing from a spherical to a planar configuration within an
evanescent field with an extension similar to the diameter of the
vesicles (SI Appendix, section 4.2). An apparent increase in size
of DOPG vesicles was also reflected in the intensity profile cross-
section of the individual vesicles (Fig. 4D), revealing an average
increase in full width at half maximum (FWHM) of 0.18 μm
(Fig. 4E). This corresponds to an average increase in footprint
diameter of ∼70%, an estimate that is certainly an un-
derestimation, as the nominal vesicle size (prior to α-synuclein
binding) is on the order of 120 nm and thus below the diffraction-
limited resolution. In contrast, DOPS vesicles showed only minor
changes in FWHM, with a narrow distribution centered around
zero (Fig. 4E).
Although the changes in fluorescence intensity are moderate
for DOPG and completely absent for DOPS, this analysis sug-
gests fairly significant α-synuclein−induced structural changes of
DOPG vesicles. This is interesting from the perspective of the
more dramatic changes observed in the scattering than the
fluorescence amplitudes. In principle, upon structural remodel-
ing of a vesicle, the lipids can form various types of structures
ranging in shape from close-packed circular patches to dispersed
and anisotropic conformations. A theoretical analysis of differ-
ent shapes and symmetries of patches (SI Appendix, section 4)
demonstrates that, if a patch is compact and symmetric (e.g.,
circular or quadratic), the scattering intensity is predicted to
either remain the same or modestly increase (SI Appendix, Fig.
S9), which is not what we observe experimentally for most of the
collapsing vesicles (Figs. 2 and 3 and SI Appendix, Figs. S6 and
S7). In contrast, the appreciable reductions in scattering intensity
frequently observed in the experiments can be explained theo-
retically only if the lipid patch formed after vesicle remodeling is
anisotropic (e.g., rectangular or ellipsoidal) and/or adopts a
dispersed shape after vesicle collapse. This interpretation of the
scattering data is further supported by nanoparticle tracking
analysis of suspended vesicles, which, for a significant fraction of
DOPG vesicles, revealed an increase in vesicles size (reduction
in diffusivity) accompanied by a dramatic decrease of their
scattering intensity (SI Appendix, Fig. S10) ∼60 min after
Fig. 3. Scattering emission of individual DOPG vesicles. Six representative
scattering intensity profiles (after subtraction of background) of single
DOPG vesicles upon exposure to 10 nM α-synuclein at t = 0. Difference in
absolute scattering intensities between these data and Fig. 2B and SI Ap-
pendix, Figs. S4–S8 is due to differences in light intensity, chip variations, and
image acquisition time. Intensity profiles were obtained using unlabeled
vesicles.
Fig. 4. Changes in single-vesicle fluorescence intensity upon addition of α-synuclein. (A) Fluorescence micrograph showing the same DOPG vesicles con-
taining 1% rhodamine before (t1 ≈ 0 s) and after (t2 ≈ 20 s) addition of α-synuclein. Red arrows indicate same vesicle identity at t1 and t2. (Scale bar: 2 μm.) (B)
Fluorescence intensity of individual DOPG (blue) and DOPS (red) vesicles before the time of α-synuclein addition (t1) and up to 40 s (t2) after addition. The lines
are linear fits to the plotted data points, and the shaded area corresponds to the mean square error of the fit. (C) A histogram of the relative change in
fluorescence intensity between times t1 and t2 for individual DOPG and DOPS vesicles. (D) Fluorescence intensity profile for cross-section of an individual
DOPG vesicle recorded at times t1 and t2. A corresponding graph for DOPS shows no difference between t1 and t2. (E) The change in cross-section FWHM
for >100 DOPG and DOPS vesicles.
























































incubation with α-synuclein at a lipid to protein molar ratio of
5:1. It cannot be excluded that the increase in vesicle size is, in
this case, also influenced by vesicle aggregation and fusion, as
previously reported for suspended anionic vesicles (47), but the
observed up to twofold increase in size is not expected to be
accompanied by a pronounced reduction in scattering intensity
unless there was a dramatic change in the shape of the vesicles
(SI Appendix, section 5 and Fig. S11).
Calcein Leakage Is Induced upon Interaction of α-Synuclein with
Tethered DOPG Vesicles. The light-scattering measurements of
individual vesicles reported here indicate that the interaction
between α-synuclein and DOPG lipids leads to stepwise
remodeling of the vesicle structure. This process is expected to
be preceded by content leakage due to pore formation or
membrane thinning, which may occur far earlier than or in
parallel with global changes in the vesicle structure. To clarify
this aspect, we assessed membrane integrity via calcein leakage
from individual DOPG and DOPS vesicles (Fig. 5A) at a calcein
concentration inside the vesicles (30 mM) where self-quenching
is insignificant. Addition of α-synuclein to a sample containing
immobilized, calcein-containing DOPG vesicles resulted in a loss
of fluorescence signal (Fig. 5B and Movie S3), while, for DOPS
vesicles, the fluorescence intensity remained more or less un-
changed throughout the analyzed time frame (Fig. 5C). Simi-
larly, whereas DOPG vesicles displayed the same drop in
scattering intensity as previously observed upon α-synuclein ad-
dition (Movie S3), the scattering signal for DOPS vesicles
remained unchanged (Movie S4). Interestingly, the decrease in
scattering and the change in calcein fluorescence were essentially
temporarily synchronized (Fig. 5C), demonstrating that there is
insignificant leakage prior to the actual vesicle collapse. This
thus implies that it is the vesicle remodeling, resulting in exten-
sive membrane rupture, that allows for the complete exchange of
content between vesicles and the surrounding environment.
Discussion
One of the most striking outcomes from this study is the re-
markable difference in the interaction of α-synuclein with
membranes composed of PG and PS, two negatively charged
lipids. DOPG vesicles collapse into disperse and/or anisotropic
patches, whereas DOPS vesicles are significantly less affected.
Notably, this difference could not be identified using ensemble-
averaging QCM-D and SPR methods but emerged from com-
bined fluorescence and label-free scattering microscopy investi-
gations of single vesicles. It is well established that α-synuclein
binds to negatively charged membranes via electrostatic inter-
actions mediated by its N-terminal region, resulting in confor-
mational changes from unordered to α-helix structure (23, 28, 48,
49). The negatively charged phosphate group of DOPS is bound
to the polar headgroup serine that has both a positive (NH3
+)
and a negative (COO−) charge, whereas the PG headgroup is
uncharged. The negative charge on PG is, instead, due to the
phosphate moiety that binds the polar headgroup with the
glycerol. Previously, we observed that α-synuclein, adopted an
α-helix structure upon binding to DOPS and DOPG vesicles, but
that a higher lipid-to-protein ratio, indicative of larger binding
surface area per protein, was needed to attain the maximum
helicity content for DOPS (28). The α-synuclein helix is thought
to lay flat on the vesicle surface, although partial penetration
into the membrane space has also been suggested (10, 50–53).
Membrane leakage and structural remodeling as observed in our
work require membrane insertion, suggesting not only that dif-
ferences in the nature and organization of the lipid headgroups
do influence membrane-induced helical transition of α-synuclein
but also that the N-terminal region of the protein is inserted
deeper into DOPG than DOPS vesicle membranes (28).
However, differences in the lipid headgroup alone are not
sufficient to explain the far-reaching different effects that
α-synuclein has on DOPG membranes compared to DOPS.
Considering the lipid bilayer properties, we note that X-ray
diffraction and NMR studies showed a higher molecular order
in the polar headgroup region of DOPS relative to DOPG in
lamellar liquid crystalline phase (54). This fact, together with
Fig. 5. Single-vesicle calcein leakage assay. (A) Schematic illustration of the assay. Vesicles are fluorescently labeled by encapsulated calcein (at a concen-
tration at which the self-quenching effect is not severe). Membrane permeabilization results in calcein release and thus in vesicle fluorescence drop. (B)
Fluorescence micrographs showing calcein containing vesicles at different time points after addition of α-synuclein. (Scale bar: 2 μm.) (C) Normalized fluo-
rescence (dashed lines) and scattering (solid lines) intensity traces for DOPG (blue) and DOPS (red) after addition of α-synuclein at t = 0.

































observations that α-synuclein binds with greater affinity to model
membranes with low lipid density, high curvature, and/or those
containing inhomogeneities (17, 26, 55, 56), is consistent with fa-
vorable interaction with DOPGmembranes over DOPS, including
deeper insertion into DOPG bilayers. In addition, previous studies
have reported that α-synuclein induces imperfections by lowering
membrane rigidity and diffusivity (57, 58), suggesting that dynamic
inhomogeneities in the structure of the lipid bilayer will likely be
enhanced by α-synuclein binding, resulting in membrane alter-
ations that may promote further protein binding. In the DOPG
membranes used here, α-synuclein−induced effects were observed
to trigger a chain of events that ultimately promoted asymmetric
vesicle collapse in close proximity to the supporting surface and
release of vesicle content.
An additional prominent aspect of our results is that a low
number of α-synuclein molecules is required to produce far-
reaching structural changes in individual vesicles. A tentative
explanation for this effect is early emergence of discrete mem-
brane regions with high (local) α-synuclein density that act as
nucleation sites for the observed membrane structural changes.
This interpretation is supported by the fact that, at low
α-synuclein coverage, the structural vesicle remodeling was oc-
casionally observed to occur in multiple distinct steps. Oligo-
meric α-synuclein has been found to cause lipid membrane
disruption, involving membrane thinning, pore formation, and
lipid clustering (16, 59–63). In addition, protofibrillar α-synuclein
species were reported to affect the integrity of surface-adsorbed
membranes containing anionic phospholipids (64). Regarding
α-synuclein monomers, they were previously described to cause
leakage of encapsulated molecules from DOPG vesicles only if
present at high concentrations: Membrane permeabilization was
observed at a protein concentration of 23 μM and a lipid:protein
molar ratio of 28, but there was no leakage at higher ratios (no
effect at a lipid:protein ratio of 81) (65). Using our single-vesicle
resolution technique, we could detect membrane structural
changes and vesicle leakage at low nanomolar concentrations of
monomeric α-synuclein and lipid:protein ratios higher than on
the order of 103. Importantly, we also revealed that α-synuclein
induced structural remodeling of DOPG vesicles that occurred in
a stepwise fashion (often single step but sometimes multiple
steps) and at low α-synuclein concentration. Although suspended
α-synuclein does not aggregate into amyloid fibrils under the
conditions used here, our data are consistent with α-synuclein
monomers clustering on the membrane surfaces such that
structural alterations and leakage are initiated by less than a
hundred protein molecules per vesicle. From inspection of the
fluorescence micrographs, it is clear that these structural changes
occur without complete disintegration and removal of lipid ma-
terial from the surface, as previously observed for, for example,
pore-forming antimicrobial peptides (35).
In conclusion, we have demonstrated that the molecular
events that appear to control how α-synuclein interacts with
different anionic lipid vesicles are difficult to pinpoint from
ensemble-averaging methods alone, regardless of whether they
are based on bulk or surface-based measurements. However,
combining ensemble-averaging methods with single-vesicle ap-
proaches that reveal information about structure and integrity of
individual lipid vesicles successfully showed that α-synuclein in-
duces membrane disruption through lipid-specific interactions
that (already at low α-synuclein binding) result in abrupt single-
step or multistep asymmetric vesicle collapse that takes place
simultaneously with content release. It is of interest that this
scenario differs from those observed in the case of antimicrobial
peptides, where the vesicle rupture is usually preceded by the
pore formation and occurs gradually or, in the case of pore
formation in giant vesicles, with subsequent gradual disintegra-
tion of the vesicles (30–35). This difference can qualitatively be
explained by taking the specifics of these systems into account. In
particular, antimicrobial peptides form small pores, and one or a
few of such peptides are not able to induce vesicle rupture (30).
In contrast, α-synuclein is a larger protein and tends to aggregate
on the surface of lipid bilayers (66). Our results for large uni-
lamellar vesicles are consistent with initial α-synuclein monomer
binding being accompanied by rapid clustering of additional
α-synuclein monomers, which appears to cause leakage via ves-
icle rupture rather than classical pore formation associated with
antimicrobial peptides. Together, these observations provide
mechanistic insights for how amyloid-forming proteins perturb
lipid membranes in general, and nanosized vesicles in particular,
and may be directly related to aberrant behavior of monomeric
α-synuclein in vivo.
Materials and Methods
Materials. DOPG and DOPS chloroform solutions, and DSPE-PEG(2000) Biotin
(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(poly-ethyl-
eneglycol)-2000], ammonium salt) were from Avanti Polar Lipids. Rhodamine
DHPE was from Invitrogen. Sodium phosphate monobasic (NaH2PO4; ≥99%),
sodium phosphate dibasic (Na2HPO4; ≥99.0%), ethylenediaminetetraacetic
acid (EDTA; ≥99%), NeutrAvidin, and calcein were purchased from Sigma-
Aldrich.
Protein Expression and Purification. Human α-synuclein construct was
expressed in Escherichia coli BL21 (DE3) (Novagen) cells at 37 °C in lysogeny
broth media containing 100 μg/mL carbenicillin. After the bacteria suspen-
sion reached an optical density at 600 nm of 0.6, the cells were induced with
1 mM isopropyl β-D-1-thiogalactopyranoside and incubated overnight at
25 °C. Bacterial pellets were resuspended in 20 mM Tris·HCl buffer pH 8.0
containing protease inhibitor mixture (Roche) and sonicated on an ice bath
using a sonicator probe in pulse mode. The lysate was treated with universal
nuclease (Pierce) for 15 min at room temperature and heated to 90 °C for
10 min followed by centrifugation at 15,000 × g for 30 min. The supernatant
was filtered through a 0.2-μm filter, loaded on to a preequilibrated 5-mL
HiTrap Q FF anion exchange column (GE Healthcare), and eluted by linear
gradient with 1 M NaCl in 20 mM Tris·HCl buffer pH 8.0. Fractions containing
α-synuclein were concentrated with Ultra-15 Ultracel 10KDa centrifugal fil-
ter devices (Millipore), applied to a Hiload 16/600 Superdex 75-pg column
(GE Healthcare), and eluted with 20 mM Tris-sulfate buffer pH 7.4. The
protein fraction was flash frozen in liquid nitrogen and stored at −80 °C.
Before each experiment, the protein was gel filtered using a Superdex 75 10/
300 GL column (GE Healthcare) and eluted with 20 mM phosphate buffer,
1 mM EDTA, pH 6.5 in order to exchange the buffer and ensure the presence
of monomers only. The protein concentration was determined by ultraviolet
(UV)-visible spectroscopy (e280 = 5,960 M
−1·cm−1).
Lipid Vesicle Preparation. Vesicles were prepared by the lipid film hydration
and extrusion method. Appropriate volumes of chloroform solution of DOPG
or DOPS were transferred to a round-bottomed flask. Biotinylated vesicles
were prepared by mixing 1% of the total lipid mass of DSPE-PEG(2000) Bi-
otin (dissolved in methanol) with DOPG or DOPS in the organic solution. In
the case of fluorescently labeled vesicles, rhodamine DHPE was also added (1
wt %) to the vesicles. The organic solvents were removed by rotary evapo-
ration, and the resultant film was dried under vacuum for at least 3 h, hy-
drated with 20 mM phosphate buffer, 1 mM EDTA, pH 6.5, and vortexed for
10 min. The size of the vesicles was reduced by extrusion using Avestin
LiposoFast-Basic extruder and 100-nm-pore-size polycarbonate membranes.
QCM-D. All measurements were performed using a Q-Sense E4 (Biolin Sci-
entific) and SiO2-coated crystals (Q-Sense, Biolin Scientific), cleaned by son-
ication (Elmasonic, Elma Schmidbauer GmbH) with sodium dodecyl sulfate
(SDS, Sigma-Aldrich) and ultrapure H2O (Synergy systems, Merck Millipore
Corporation) prior to drying with a flow of N2 and UV/Ozone treatment (UV/
Ozone Procleaner Plus, BioForce Nanosciences) for 30 min. The baseline was
normalized with the phosphate buffer described above prior to each ex-
periment. At the start of the experiment, the sensor surface was coated
with 10 μg/mL PLL-g-PEG (PLL (20)-g[3.5]-PEG (2) from SuSOS AG), with
0.25% or 1% of the PLL-g-PEG functionalized with biotin (PLL (20)-g[3.5]-
PEG (2)/PEGbiotin(3.4) 50% from SuSOS AG). When saturation was reached,
NeutrAvidin was added at 10 μg/mL concentration until no further bind-
ing was observed. To this, vesicles (100 μg/mL lipid concentration) con-
taining 1% biotinylated lipids were added until reaching saturation
























































followed by α-synuclein. The sample cells were rinsed with buffer be-
tween every addition.
MP-SPR. The dual-wavelength surface plasmon resonance (SPR) measure-
ments were performed with an SPR Navi 220A (BioNavis) on SiO2-coated
chips (SPR102-SIO2, BioNavis), first cleaned by rinsing in 10 mM SDS with
subsequent rinsing in ultrapure water. After rinsing, the chips were dried in
nitrogen flow and then treated with UV/Ozone (UV/Ozone Procleaner Plus,
BioForce Nanosciences, Inc.) for 30 min. After the washing procedure, the
chip was then docked in the SPR instrument and primed with circulating
buffer at 20 μL/min. The chip was coated with PLL-g-PEG-biotin:PLL-g-PEG
and vesicles tethered through NeutrAvidin as described for QCM-D experi-
ments, and SPR was monitored at wavelengths 670 and 785 nm for a scan-
ning interval between ∼65° and 78°. The measurements were performed at
21 °C.
Waveguide Chip Fabrication and Surface Modification. The fabrication of the
waveguide device is described in detail elsewhere (67). Briefly, a 400-nm-thick
silica core layer (spin-on-glass, IC1-200 from Futurrex, Inc.), embedded in a 7-
μm-thick cladding layer of fluorinated polymer (CYTOP, CTX-809AP2 from
AGC Chemicals, ASAHI Glass Co., Ltd.), was fabricated on a standard Si(100)
4-inch wafer. Square wells with a side length of 2 mm were formed in the
cladding layer by reactive etching exposing the core layer of the waveguide.
Before being used for experiments, the chips were treated for 15 min in O2
plasma (Harrick Plasma cleaner, 30 W), followed by cleaning in 2 M sulfuric
acid (H2SO4) for 30 min before subsequent extensive rinsing in ultrapure
water and drying in nitrogen gas. Before the experiments, cleaned wave-
guide chips were incubated first with PLL-g-PEG (10 μg/mL), of which 1%
were modified with biotin, for 20 min. The chips were then rinsed with ul-
trapure water. Any remaining water was removed using a pipette (a small =
5-μL drop remained on top of the sample area of the waveguide). After this,
NeutrAvidin was added and kept for 20 min. The rinsing procedure was
repeated before addition of 20 μL of buffer. Vesicles (10 μg/mL lipid con-
centration) were then added under observation in the microscope. When a
sufficient amount of vesicles had bound to the surface, the binding process
was stopped by aspirating the vesicle solution with a pipette, while replacing
it with an equal volume of buffer. Movie recordings were started before
adding a small volume of α-synuclein using a pipette to a final α-synuclein
concentration of 200 nM. After addition, the system was mixed using
a pipette.
Microscopy Setup. All waveguide measurements were carried out on an
Olympus BX61 upright microscope equipped with a 100×, NA 1.0 Leica water-
dipping objective and a Hamamatsu ORCA Flash 4.0 V2 scientific comple-
mentary metal oxide semiconductor (CMOS) camera connected to a Hama-
matsu W-VIEW GEMINI image splitter containing specific filter cubes
(dichroic mirror: 562 nm; fluorescence band-pass: 590/50; and scattering
band-pass: 535/50) allowing for simultaneous acquisition of fluorescence
and scattering signals. A functionalized waveguide chip was placed under
the objective, and single-mode, 532-nm, TE polarized light (from fiber-
coupled NANO 250 [Qioptiq, Inc.] Laser) was butt-coupled into the chip via
a single-mode fiber that was carefully aligned to the facet of the waveguide
using a manual three-axis translational stage. Once aligned, a solution
containing vesicles was exposed to the chip, and the surface binding of
vesicles was monitored in real time. When a suitable surface coverage had
been reached, the chip was rinsed with buffer and subsequently exposed to
α-synuclein. For further details on the waveguide chip and experimental
setup, see ref. 67.
Single-Vesicle Scattering and Fluorescence Measurements. Surface-tethered
lipid vesicle samples were prepared as described above. The sample was
imaged using the microscope setup described above with a 100-ms in-
tegration time at 0.1 frames per s. Scattering and fluorescence signals were
recorded simultaneously by using an image-splitting device. Recorded im-
ages were analyzed in ImageJ. First, the corresponding fluorescence and
scattering images were aligned using a built-in alignment module in
ImageJ. Single-vesicle intensities were then obtained by integrating the in-
tensity within an area confining the vesicle signal. This area was defined at
the end of the recording, for the fluorescence data (signal footprint growing
with time), and at the beginning of the recording, for the scattering data
(signal footprint remaining essentially constant with time). Mean back-
ground intensity per pixel was evaluated locally for each vesicle and sub-
tracted from its integrated scattering and fluorescence intensity.
Leakage Assay. Biotinylated vesicles with encapsulated calcein at a concen-
tration of 30 mM, at which the self-quenching effect is sufficiently weak to
enable the individual vesicles to be detectable, were prepared by hydrating
the lipid film with phosphate buffer containing the dye. Calcein was dis-
solved in alkaline environment (1 M NaOH) and then diluted with phosphate
buffer (20 mM phosphate buffer, 1 mM EDTA, pH 6.5). The vesicles were
vortexed, extruded, and immobilized on the chip surface as described pre-
viously. Free calcein was removed by washing the immobilized vesicles with
phosphate buffer before adding α-synuclein. Fluorescence emission was
detected using a 100-ms integration time. An image was recorded every 2 s
in order to allow prolonged recording times without causing substantial
bleaching of the dyes in the sample. It should be noted that the presence of
calcein inside vesicles has an apparent negative impact on the ability of
α-synuclein to interact with the lipid membranes used in this study. To ob-
tain a similar level of interaction, as measured by QCM-D (presented in SI
Appendix), a 10-fold higher α-synuclein concentration was required. This
means that quantitative results obtained using the different methods are
not directly comparable.
Data availability. All data and procedures are provided in the manuscript and
SI Appendix.
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